Protection from articular damage by passive or active anti-tumour necrosis factor (TNF)-α immunotherapy in human TNF-α transgenic mice depends on anti-TNF-α antibody levels.
Clin Exp Immunol
; 172(1): 54-62, 2013 Apr.
Article
in En
| MEDLINE
| ID: mdl-23480185
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Arthritis, Rheumatoid
/
Cartilage, Articular
/
Immunotherapy, Active
/
Immunization, Passive
/
Tumor Necrosis Factor-alpha
/
Antirheumatic Agents
/
Antibodies
Type of study:
Prognostic_studies
Limits:
Animals
Language:
En
Journal:
Clin Exp Immunol
Year:
2013
Type:
Article
Affiliation country:
France